Understanding What Dose of Ozempic to Lose Weight

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing gastric emptying and activating GLP-1 receptors in the brain to reduce hunger signals. The typical dosing protocol starts at 0.25 mg weekly and increases every four weeks, with most patients reaching effective doses between 1.0 and 2.4 mg weekly. PlexusDx provides access to compounded semaglutide from licensed 503A pharmacies, allowing you to find your optimal dose without price surprises.

How Semaglutide Dosing Schedules Work for Weight Loss

Semaglutide dosing follows a tiered escalation plan designed to help your body adjust to the medication while reducing nausea and gastrointestinal side effects. Most patients begin at 0.25 mg once weekly for four weeks, then advance to 0.5 mg weekly if tolerated. This gradual approach allows your GLP-1 receptors to become sensitized to the drug, improving appetite suppression and metabolic effects over time.

The standard dose escalation continues with increases to 1.0 mg, 1.7 mg, and finally 2.4 mg at four-week intervals. However, not every patient needs to reach the maximum dose to see meaningful weight loss—clinical data shows significant results occur at 1.0 to 1.7 mg weekly for many individuals. Your response depends on genetics, baseline metabolism, and how well you tolerate each dose level.

PlexusDx customizes your dosing journey by monitoring your progress and adjusting based on your individual results. Your dose may need to go up—your price won't. Compounded semaglutide from PlexusDx is $189 per month month-to-month, or from $149/mo on the 6-month plan regardless of which dose your body requires, removing the financial barrier to dose optimization.

Starting Dose vs. Maintenance Dose: What to Expect

The starting dose of 0.25 mg is intentionally modest and typically produces mild appetite reduction without severe side effects. Many patients report a subtle decrease in cravings and food intake at this initial level, but dramatic weight loss usually doesn't occur until weeks 8-12 when doses reach 1.0 mg or higher. This measured beginning gives your kidneys, liver, and digestive system time to adapt to the medication's effects.

Maintenance doses—the levels where you stay consistent for weeks or months—typically range from 1.0 to 2.4 mg weekly based on your weight loss goals and tolerance. Some patients maintain excellent results at 1.0 or 1.7 mg and choose not to advance further, while others benefit from reaching 2.4 mg. Your healthcare provider at PlexusDx helps determine when you've found your effective maintenance dose by reviewing your weight loss progress and side effect profile.

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Semaglutide Dose Titration: Why Slow and Steady Wins

Rapid dose increases are avoided because they dramatically increase nausea, vomiting, and other gastrointestinal symptoms that lead to medication discontinuation. Clinical trials show that four-week intervals between dose escalations allow your body's receptors to fully activate and your gut to acclimate, resulting in better tolerability and sustained weight loss over time. Patients who skip dose escalations or jump to higher doses too quickly often experience severe side effects and lose adherence.

The titration schedule also reveals your personal tolerance threshold—the highest dose your body can comfortably manage while still delivering weight loss benefits. Some individuals feel excellent at 1.0 mg weekly and experience minimal side effects, while others need the full 2.4 mg dose to suppress appetite effectively. Respecting this personalized titration window prevents unnecessary side effects and maximizes long-term medication compliance.

During titration, keeping a simple food and symptom journal helps you and your PlexusDx provider identify patterns in how your body responds to each dose increase. This real-world data guides decisions about whether to continue advancing doses or maintain at your current level. Most patients complete the full titration sequence over 16-20 weeks, arriving at their optimal maintenance dose by month 5 or 6 of treatment.

Personalizing Your Semaglutide Dose with Genetic Testing

The PlexusDx Precision Peptide Genetic Test analyzes FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The test examines key variants like, which affects how efficiently your cells respond to semaglutide stimulation, and FTO rs9939609, which influences baseline metabolic rate and hunger regulation. Patients carrying certain variants may achieve target weight loss at lower doses (saving time and minimizing side effects), while others may benefit from higher doses or dual-compound protocols like GLP-Squared (semaglutide plus tirzepatide). For $298 added to your first month of treatment, the Precision Peptide Genetic Test eliminates guesswork from dose selection.

Combining genetic insights with your clinical response during titration creates a truly personalized dosing strategy. Rather than following a one-size-fits-all protocol, PlexusDx uses your genetic predispositions alongside your actual weight loss and tolerance data to recommend the dose most likely to deliver results. This precision approach often shortens the titration timeline and increases patient confidence in their treatment plan.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected subcutaneously once weekly. After four weeks, the dose increases to 0.5 mg weekly, with further increases every four weeks (1.0 mg, 1.7 mg, 2.4 mg) based on tolerance and response. PlexusDx monitors your progress and adjusts your dosing timeline according to your individual needs.

How much weight can I expect to lose on each semaglutide dose level?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Does the price of semaglutide at PlexusDx change when my dose increases?

No. PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and remains flat across all dose levels—your dose may need to go up, your price won't. This transparent pricing removes financial barriers to dose optimization and ensures you can reach your therapeutic dose without unexpected cost increases.

What are the most common side effects at higher semaglutide doses?

Nausea, vomiting, constipation, and decreased appetite are most frequent at doses above 1.0 mg. These effects typically diminish within 1-2 weeks as your body adjusts. Slowing your dose escalation schedule and staying hydrated reduces symptom severity—PlexusDx providers can pause or extend titration intervals if side effects become uncomfortable.

Can genetic testing help me find the right semaglutide dose faster?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (FTO and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Losing Weight
• Ozempic For Weight Loss 2
• Ozempic Starting Dose
• Average Weight Loss On Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.